Summary We have studied whether N-methylformamide can affect the expression pattern of adhesion molecules and the attachment behaviour of M14 human melanoma cells. The role of N-methylformamide on experimental and spontaneous pulmonary metastases from M14 cells in nude mice was also investigated. We demonstrate that N-methylformamide in vitro pretreatment of M14 cells, although inducing a significant increase in the expression of a2,1l, a611 and avj3 integrin receptors, slightly modifies a5p1 heterodimer and P1 subunit expression. After this modulation, enhancement of cell adhesion to laminin, collagen 1, vitronectin and fibrinogen, which is blocked by specific anti-integrin antibodies, also occurs. No changes in binding to fibronectin are observed. In vitro N-methylformamide pretreatment also results in an increased number of experimental nodules and in a decrease in spontaneous metastases. Moreover, in vivo treatment with Nmethylformamide significantly reduces the number of spontaneous metastases. Collectively, these data show that N-methylformamide modulates the expression of some adhesion receptors, cell adhesion to laminin, collagen 1, vitronectin and fibrinogen as well as the metastatic behaviour of M14 cells. Our data also suggest that the effect of N-methylformamide might be evaluated in combination with antineoplastic agents for the treatment of human melanoma.
Understanding of the process of metastasis is essential in the management of cancer as most deaths occur because of metastatic disease. Crucial steps in the process of metastasis are the release and migration of tumour cells from the primary site, penetration of the blood vessel wall, arrest in the microcirculation of distant organs and subsequent extravasation (Liotta and Stetler-Stevenson, 1991) . The adhesion, invasion and metastatization of tumour cell can be controlled by extracellular matrix (ECM) components that form tissue barriers and act as adhesive substrates (Ruoslahti, 1992) . Furthermore, the ECM transmits signals to the cells through the receptors that mediate adhesion, growth factors and matrix bound cytokines (Ruoslahti, 1992) .
A number of recent observations indicate that cell adhesion molecules (CAMs), by virtue of their ability to mediate the interaction of tumour cells with extracellular matrix components and with other cells, also play a crucial role in the multistep process of metastasis formation (Hynes and Lander, 1992) . At least four categories of CAMs are currently recognized, including integrins (Hemler, 1990 ), a subset of molecules of the immunoglobin supergene family (Williams, 1987) , a number of the LEC-CAM family (Stoolman, 1989) and cell surface proteoglycans (Ruoslahti, 1989) . It has been demonstrated that qualitative as well as quantitative changes in CAMs expression (including their decrease, enhancement and appearance) occur during tumour progression of malignant human tumours, including melanoma (Hart et al, 1991 ; Mortarini and Anichini, 1993; Timar et al, 1996) . In particular, the ,1 and P3 subfamilies of integrins are involved in tumour progression and metastasis (Felding-Habermann et al, 1992; Seftor et al, 1992; Danen et al, 1993; Natali et al, 1993; Schadendorf et al, 1993) . Therefore, CAMs might represent an ideal target for new agents that are able to alter their expression and to inhibit specific steps in the metastatic process (Reich et al, 1988; Wang and Steams, 1988) .
Among these putative candidates, N-methylformamide (NMF) is a differentiating compound that has been shown to affect metastasis in several murine tumour cells, including lung carcinoma (Greco et al, 1990) , hepatocarcinoma Iwakawa et al, 1987) , neuroblastoma (Iwakawa et al, 1994) and mammary carcinoma (Iwakawa et al, 1987; Iwakawa et al, 1989) . Depending on the experimental setting, NMF may exert both enhancing and inhibiting effects on tumour metastases. In particular, the enhancement of metastases is observed when murine tumour cells are treated with NMF before intravenous inoculation Takenaga, 1984) , whereas there is a reduction when the agent is given after tumour cell inoculation (Iwakawa et al, 1987; Tofilon et al, 1987; Greco et al, 1990; Iwakawa et al, 1994) .
As the tendency of tumour cells to leave the primary tumour mass implies at least temporary changing of the original intercellular interaction, the purpose of this study was to evaluate whether NMF is able to alter the expression of some adhesion molecules and the metastatic ability of a human tumour cell line. To address this issue we chose a well characterized experimental model available in our laboratory that uses the melanoma M14 cell line (Greco and Zupi, 1987) . In particular, we analysed whether (a) NMF treatment modulates the expression of some integrins and the attachment behaviour of M14 line; (b) in vitro NMF pretreatment of M14 cells affects spontaneous and experimental metastases; and (c) in vivo NMF treatment of nude mice bearing M14 tumours interferes with the metastatic capacity.
MATERIALS AND METHODS Cell culture and N-methylformamide treatment
The human malignant melanoma cell line M14 (Greco and Zupi, 1987) 
Cell adhesion and inhibition assay
Flat-bottom 96-well plates (Costar, Cambridge, MA, USA) were precoated with one of the following compounds dissolved in phosphate-buffered saline (PBS): collagen I (Coll I, 10 jg ml', Sigma), laminin (LN, 2 ig ml', Gibco, UK), fibronectin (FN, 5 ,ug ml-', Sigma), vitronectin (VN, 1 ,ug ml-', Telios), and fibrinogen (FB, 5 , Sigma) . The compounds were left to absorb in the wells overnight at 40C. The plates were rinsed three times with PBS and then incubated at room temperature for 1 h with 200 g1 of PBS containing 1% BSA (Sigma) to prevent nonspecific cell adhesion. Control cells or cells treated 24 h with 170 mm NMF were labelled by incubation with chromium-S 1-labelled sodium chromate (50 gCi per 106 cells) for 1 h at 37°C.
After two washings with RPMI medium containing 1% bovine serum albumin (BSA) 5 x 104 of the labelled cells were added to each well in 100 jl of serum-free medium. After 30, 60 and 120 min incubation at 37°C, wells were washed with PBS to remove non-adherent cells, and attached cells were lysed with 2% sodium dodecyl sulphate (SDS) for 10 min. The radioactivity was counted using a gamma counter (LKB 1261 Multigamma) and the percentage of cell adhesion was calculated as follows: In experiments in which anti-human integrin antibodies were tested, labelled cells were incubated in the presence of either the control culture medium or the dilution of antibodies for 1 h at 4°C.
Then, the cells were plated and the number of adherent cells was determined after 1 h adhesion as above. As a negative control, adhesion to 1 % BSA was determined. All the experiments were carried out in quadruplicate.
Evaluation of metastatic ability in athymic mice
Six-to eight-week-old male CD-I nude (nu/nu) mice, purchased from Charles River Laboratory (Calco, Italy) were used. Mice were housed under pathogen-free conditions and received acidified and sterilized water and y-irradiated commercial food ad libitum. Manipulations were carried out under sterile conditions in a laminar air flow hood. Each experimental group of mice included 10-20 animals.
The effect of in vitro pretreatment with NMF (170 mm for 24 h) on M 14 experimental and spontaneous metastases was evaluated by injecting mice with 1 x 106 viable cells via the tail vein (intravenous, i.v) or by injecting 1 x 107 viable cells into the muscle of the hind leg (intramuscular, i.m.). For spontaneous metastases experiments, we have chosen the i.m. injection because this kind of implantation resulted in more homogeneous tumour growth than that obtained using a subcutaneous implant and obtained 100% take after tumour cell injection. Spontaneous lung metastases were observed in all mice given i.m. tumour cell injections.
The effect of in vivo NMF treatment on spontaneous metastases was assessed by implanting mice i.m. with I x 107 viable cells. Twenty-four hours later, NMF at 200 mg kg' day was injected Laminin intraperitoneally (i.p.) for 12 consecutive days. The number of experimental and spontaneous metastases were evaluated on days 28 and 35 after tumour implant respectively. The mice were killed and the lungs were excised and fixed in Bouin's solution and the median number of metastatic nodules counted with the aid of a dissecting microscope. The mice were also examined daily and tumour growth was monitored, as reported previously (Greco et al, 1990) .
The results were analysed by the Mann-Whitney U-test for statistical significance. Differences were considered significant at P-values < 0.05 (two-sided).
All 
RESULTS

Effect of N-methylformamide on integrin expression
To determine whether NMF affects the expression of some integrins involved in metastasis, M14 cells were treated in vitro with 170 mm NMF for 24 h and at the end of treatment the cells were analysed by flow cytometry.
As shown in Figure 1, Time (min) Figure 2 Time dependent analysis of cell adhesion (30, 60 and 120 min) of NMF-treated (-) and -untreated (Lii) M14 cells. Laminin (2 !tg ml-'), collagen (10 pg ml-'), vitronectin (1 pg ml-'), fibrinogen (5 pg ml-') and fibronectin (5 pg ml-1) were used as substrates. Figure 3 Inhibition of adhesion of NMF-treated (-) and -untreated (E) M14 cells to laminin (2 gg ml-1), collagen I (10 gg ml-1), vitronectin (1 jg ml-'), and fibrinogen (5 gg ml-1). A 60-min adhesion assay was used to test the function blocking effects of the following antibodies: anti-51 (4B4, ascites, 1:20 dilution), anti-a6 (GoH3, 10 jg ml-'), anti-a2 (P1 E6, ascites, 1:500 dilution), anti-53 (RUU-PL7F12, 2 jg ml-1), and anti-,B5 (P1 F6, ascites, 1:500 dilution Effect of N-methylformamide on cell adhesion to laminin, collagen 1, fibronectin, vitronectin and fibrinogen A time-dependent analysis of cell adhesion ranging from 30 to 120 min was performed to establish whether differences in cell-surface expression between NMF-treated and -untreated cells could reflect differences in the level of attachment to LN, Coll I, FN, VN and FB. As shown in Figure 2 , adhesion of untreated M14 cells to FN was greater than that to LN, Coll I, VN and FB for all the observed times. After a 60-min adhesion assay, approximately 70% of cells adhere to FN whereas approximately 10-25% of them adhere to LN, Coll I, VN and FB. Treatment with 170 mM NMF for 24 h induces an increase in cell attachment to LN, Coll I, VN and FB, ranging from 45% to 75%. In all cases except for VN, this increase is evident at all times, starting from 30-min adhesion time. In contrast, the effect of NMF on the adhesion to VN is only clearly evident at adhesion times less than 120 min; the percentage of increase in cell adhesion is about 80% and 55% after 30 and 60 min, respectively, and only 10% after 120 min.
No differences in cell adhesion to FN were observed between NMF-treated and -untreated cells, even at the shortest time period.
Effect of anti-integrin antibodies on cell adhesion
To evaluate the specific role of some integrins in mediating the adhesive properties of M14 cells to Coll I, LN, VN and FB, an antibody inhibition assay was performed (Figure 3) . The monoclonal antibody directed against the P1 subunit reduced the adhesion of untreated M14 cells to LN and Coll I but not to VN and FB. The monoclonal anti-a6 antibody inhibited adhesion to LN but not to Coll I. The monoclonal anti-a2 antibody inhibited adhesion to Coll I. Anti-,3 antibodies inhibited adhesion to both VN and FB but not to LN; whereas anti-avP5 antibodies inhibited adhesion to VN. Similar inhibition was observed when NMF-treated cells were preincubated with the same antibodies.
Anti-,3 and -a6 were used as controls for adhesion to LN and Coll I respectively. Anti-,B1 was used as control for adhesion to VN and FB. Effect of N-methylformamide on M14 metastatic ability To investigate whether a correlation exists between the capacity to adhere to ECM compounds in vitro and the metastatic potential of M14 cells, the effect of NMF on experimental and spontaneous metastases was evaluated. The results that are reported in Table 1 summarize the effects of in vitro NMF treatment on the experimental and spontaneous pulmonary metastases. The effect of NMF administration in M14 tumour-bearing mice on spontaneous metastases was also reported. The median number of experimental and spontaneous lung nodules was evaluated on days 28 and 35 after the injection of cells respectively. It is evident that the in vitro treatment with NMF produces a statistically significant increase in the median number of experimental metastases compared with untreated cells (18 vs 8, P = 0.01), whereas the median number of spontaneous-metastases is significantly reduced (11 vs 16, P = 0.012). The in vivo NMF treatment of mice bearing M14 tumours leads to a significant decrease in lung metastases compared with control animals (6 vs 16, P = 0.0001).
The effect of NMF on primary tumour growth was also evaluated. The data demonstrate that in vivo NMF treatment does not significantly affect primary tumour growth. In fact, the tumour weight in grams evaluated at the nadir of the NMF effect, is 1370 mg ± 258 and 1187 mg ± 302 for untreated and NMF-treated mice respectively. (Chen et al, 1992; Timar et al, 1996) we found no expression of this integrin in M14 cells. The fact that the M14 cells express the av but not the aIIb subunit indicates that the 03 integrin molecule is expressed on the surface of M14 cells in the form of a heterodimer av,B3.
The increase in the expression of a2pl, a6,1 and avP3 receptors leads to functional changes affecting the binding of the three integrins for their ligands. Indeed, we demonstrate that NMF is able to increase the adhesion of M14 cells to LN, Coll I, VN and FB. We also show that long time periods of cell adhesion may obscure differences in the initial matrix interaction process. In fact, in the case of VN the effect of NMF on the adhesion is only clearly evident at the adhesion times less than 120 min. It is possible that long time periods allow metabolic activities, such as modifications of the provided matrices and deposition of additional matrix protein, which may affect the outcome of the adhesion assay. Our data also show that the adhesion of untreated and NMF-treated cells to LN and Coll I is mediated by a601 integrin and a2p1
respectively; adhesion to VN is mediated by both avP3 and avP5
receptors, whereas adhesion to FB is mediated by avP3 integrin.
We also demonstrate that the relatively small increase in a5OP expression is not sufficient to have an impact on FN binding, even when using short time periods of adhesion assay. The observation that NMF does not modulate adhesion to FN confirms the results of a number of previous studies in which no positive correlation was observed between the capability of cells to adhere to FN and their tumorigenic and/or metastatic behaviour (Terranova et al, 1984; Dedhar and Saulnier, 1990) . To assess whether the modulation of the cell adhesion pattern by treatment with NMF can modify the metastatic potential, we determined the NMF effect on experimental and spontaneous pulmonary metastasis of nude mice injected with M14 cells.
We have shown that in vitro NMF pretreatment of M14 cells exerts an enhancing effect on experimental tumour metastasis. In vitro adhesion data provide a possible explanation regarding the metastatic cell behaviour after NMF pretreatment. It is possible that the enhanced expression of some integrin receptors induced by NMF alters the adhesion to blood vessels and mediates cell-cell and cell-matrix interactions. In addition, in murine model systems it has been reported that in vitro NMF pretreatment increases the number of experimental lung colonies (Takenaga, 1984; . In addition, our findings add further evidence to that of other authors, demonstrating a correlation between increased expression of some integrin receptors and enhanced metastatic capacity (Takenaga, 1984; Terranova et al, 1984; Chan et al, 1991; Gehlsen et al, 1992; Mortarini and Anichini, 1993; Schadendorf et al, 1993; Timar et al, 1996) .
We also show that spontaneous metastases decrease both after the injection of in vitro NMF pretreated cells and after the in vivo treatment of tumour bearing mice with NMF for 12 days. However, a significant difference in the number of metastases between NMF in vitro treatment and NMF in vivo administration is observed (6 vs 11, P = 0.015). The continuous treatment of animals with NMF could also exert an effect on the host that may be responsible for this difference. We suggest that NMF treatment might exert a direct effect on the primary tumour, altering the expression of some cell adhesion receptors. In the present model, NMF-induced upregulation of some adhesion molecules may facilitate both the tumour cell adhesion at the site of growth and cell-cell interaction, thus reducing the number of cells able to detach from the growing primary tumour. Moreover, NMF may also inhibit spontaneous metastases affecting the host endothelial integrins, such as avP3. In fact, avP3 adhesion receptor has been recently identified as a marker of angiogenic blood vessels in chickens and man (Brooks et al, 1994a ) and antagonists of these integrins induces apoptosis of the proliferative angiogenic vascular cells (Brooks et al, 1994b) .
The effect of NMF on spontaneous metastases has also been demonstrated previously in different model systems, and several mechanisms have been postulated for the antimetastatic effect of the agent (Iwakawa et al, 1987; Tofilon et al, 1987; Iwakawa et al, 1989; Greco et al, 1990; Iwakawa et al, 1994) . It has been hypothesized that NMF may induce tumour cells to form a less aggressive differentiated phenotype, resulting in a decrease in metastatic potential (Spremulli and Dexter, 1984) . In a previous paper we demonstrated that NMF produces a significant increase in splenic NK cell activity in Lewis lung carcinoma-bearing mice and we suggested that NMF could promote differentiation of NK precursor cells in tumour-bearing hosts in which maturation defects had been caused by the neoplastic disease (Greco et al, 1990) . Alternatively, NMF could act as an immunomodulating agent whose effect is specifically detectable in immunodepressed hosts (Parhar and Lala, 1985) . Finally, other authors have suggested that NMF may act by exerting a stress-like reaction upon the host (Nicolson and Custead, 1985) .
In conclusion, the results of the present work suggest that NMF might be used in combination with antineoplastic agents for the treatment of human melanoma.
